[NBY] YoY Quarter Result on 30-Jun-2022 [#Q2]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
11-Aug-2022
Financial Year
2022
Quarter
30-Jun-2022 [#Q2]
Profit Trend
QoQ- -1,841.44%
YoY- -15.92%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 2,400 4,610 3,045 2,133 3,984 1,789 2,794 -2.49%
PBT -1,585 -2,036 -2,155 -1,859 -4,481 -2,499 -1,588 -0.03%
Tax 0 -256 3 300 1 2 1 -
NP -1,585 -4,032 -2,155 -1,859 -4,482 -2,530 -1,589 -0.04%
Tax Rate - - - - - - - -
Total Cost 3,985 8,642 5,200 3,992 8,466 4,319 4,383 -1.57%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin -66.04 -87.46 -70.77 -87.15 -112.50 -141.42 -56.87 2.52%
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -1.37 -40.92 -50.05 -53.51 -180.70 -166.51 -113.91 -52.10%
EPS Diluted -1.37 -40.92 -50.05 -53.51 -180.70 -166.51 -147.28 -54.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.